These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6418829)

  • 1. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum.
    Levy J; Smith AL; Kenny MA; Ramsey B; Schoenknecht FD
    J Infect Dis; 1983 Dec; 148(6):1069-76. PubMed ID: 6418829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of gentamicin in bronchial secretions of children with cystic fibrosis of tracheostomy. (Comparison between the intramuscular route, the endotracheal instillation and aerosolization).
    Baran D; Dachy A; Klastersky J
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):336-41. PubMed ID: 809371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
    Mendelman PM; Smith AL; Levy J; Weber A; Ramsey B; Davis RL
    Am Rev Respir Dis; 1985 Oct; 132(4):761-5. PubMed ID: 3931522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microflora study and the pharmacokinetic characteristics of gentamycin in children with mucoviscidosis].
    Skala LZ; Klimova VS; Shabalova LA
    Antibiotiki; 1984 Jan; 29(1):49-51. PubMed ID: 6696404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study.
    Crowther Labiris NR; Holbrook AM; Chrystyn H; Macleod SM; Newhouse MT
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1711-6. PubMed ID: 10556145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.
    Laferriere C; Stutman HR; Marks MI; Kramer J; Flux M
    Chemotherapy; 1985; 31(4):255-60. PubMed ID: 3928280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pus, deoxyribonucleic acid, and sputum viscosity.
    Picot R; Das I; Reid L
    Thorax; 1978 Apr; 33(2):235-42. PubMed ID: 26989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa.
    Davis SD; Bruns WT
    Am Rev Respir Dis; 1978 Jan; 117(1):176-8. PubMed ID: 413461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis].
    de Meirleire F; Fauchere JL; Simon G
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ceruloplasmin, haptoglobin and transferrin levels in bronchial secretions of children with chronic respiratory tract diseases].
    Gaweł J; Herman T; Zebrak J
    Probl Med Wieku Rozwoj; 1984; 13():84-90. PubMed ID: 6531357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis.
    Savelev SU; Perry JD; Bourke SJ; Jary H; Taylor R; Fisher AJ; Corris PA; Petrie M; De Soyza A
    Lett Appl Microbiol; 2011 Jun; 52(6):610-3. PubMed ID: 21438899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that Pseudomonas aeruginosa elastase does not inactivate the bronchial inhibitor in the presence of leukocyte elastase. Studies with cystic fibrosis sputum and with pure proteins.
    Tournier JM; Jacquot J; Puchelle E; Bieth JG
    Am Rev Respir Dis; 1985 Sep; 132(3):524-8. PubMed ID: 2412473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of mucoid Pseudomonas aeruginosa to gentamicin disks.
    Anderson EL
    South Med J; 1974 Jul; 67(7):771-2. PubMed ID: 4209405
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.
    Potter JL; Spector S; Matthews LW; Lemm J
    Am Rev Respir Dis; 1969 Jun; 99(6):909-16. PubMed ID: 5787605
    [No Abstract]   [Full Text] [Related]  

  • 18. Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis.
    Lloberes P; Montserrat E; Montserrat JM; Picado C
    Thorax; 1992 Feb; 47(2):88-92. PubMed ID: 1372451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchial secretion and blood levels of gentamicin, in gentamicin treated children with mucoviscidosis].
    Vogt E
    Schweiz Rundsch Med Prax; 1973 Apr; 62(14):444-7. PubMed ID: 4572076
    [No Abstract]   [Full Text] [Related]  

  • 20. Nebulised gentamicin-suitable for childhood bronchiectasis.
    Twiss J; Byrnes C; Johnson R; Holland D
    Int J Pharm; 2005 May; 295(1-2):113-9. PubMed ID: 15847996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.